Mullins CD - Search Results

1

Cost-effectiveness of rosuvastatin compared with other statins from a managed care perspective.

Benner JS, Smith TW, Klingman D, Tierce JC, Mullins CD, Pethick N, O'Donnell JC. Benner JS, et al. Among authors: mullins cd. Value Health. 2005 Nov-Dec;8(6):618-28. doi: 10.1111/j.1524-4733.2005.00055.x. Value Health. 2005. PMID: 16283862 Free article.

2

Comparing cost-effectiveness analyses of anti-hypertensive drug therapy for decision making: mission impossible?

Mullins CD, Blak BT, Akhras KS. Mullins CD, et al. Value Health. 2002 Jul-Aug;5(4):359-71. doi: 10.1046/j.1524-4733.2002.54142.x. Value Health. 2002. PMID: 12102698 Free article. Review.

3

An economic evaluation of triptan products for migraine.

Perfetto EM, Weis KA, Mullins CD, Subedi P, Healey PJ Sr. Perfetto EM, et al. Among authors: mullins cd. Value Health. 2005 Nov-Dec;8(6):647-55. doi: 10.1111/j.1524-4733.2005.00056.x. Value Health. 2005. PMID: 16283865 Free article.

4

Using cost-effectiveness analysis to sharpen formulary decision-making: the example of tiotropium at the Veterans Affairs health care system.

Onukwugha E, Mullins CD, DeLisle S. Onukwugha E, et al. Among authors: mullins cd. Value Health. 2008 Sep-Oct;11(5):980-8. doi: 10.1111/j.1524-4733.2007.00314.x. Epub 2008 Jan 11. Value Health. 2008. PMID: 18194405 Free article.

5

Cost-effectiveness of intensive atorvastatin treatment in high-risk patients compared with usual care in a postgeneric statin market: economic analysis of the Aggressive Lipid-lowering Initiation Abates New Cardiac Events (ALLIANCE) study.

Mullins CD, Rattinger GB, Kuznik A, Koren MJ. Mullins CD, et al. Clin Ther. 2008;30 Pt 2:2204-16. doi: 10.1016/j.clinthera.2008.12.007. Clin Ther. 2008. PMID: 19281915

6

Good research practices for measuring drug costs in cost-effectiveness analyses: Medicare, Medicaid and other US government payers perspectives: the ISPOR Drug Cost Task Force report--Part IV.

Mullins CD, Seal B, Seoane-Vazquez E, Sankaranarayanan J, Asche CV, Jayadevappa R, Lee WC, Romanus DK, Wang J, Hay JW, Smeeding J. Mullins CD, et al. Value Health. 2010 Jan-Feb;13(1):18-24. doi: 10.1111/j.1524-4733.2009.00604.x. Epub 2009 Oct 6. Value Health. 2010. PMID: 19807903 Free article.

7

Good research practices for measuring drug costs in cost effectiveness analyses: issues and recommendations: the ISPOR Drug Cost Task Force report--Part I.

Hay JW, Smeeding J, Carroll NV, Drummond M, Garrison LP, Mansley EC, Mullins CD, Mycka JM, Seal B, Shi L. Hay JW, et al. Among authors: mullins cd. Value Health. 2010 Jan-Feb;13(1):3-7. doi: 10.1111/j.1524-4733.2009.00663.x. Epub 2009 Oct 28. Value Health. 2010. PMID: 19874571 Free article.

8

Generating evidence for comparative effectiveness research using more pragmatic randomized controlled trials.

Mullins CD, Whicher D, Reese ES, Tunis S. Mullins CD, et al. Pharmacoeconomics. 2010;28(10):969-76. doi: 10.2165/11536160-000000000-00000. Pharmacoeconomics. 2010. PMID: 20831305

9

Comparative and cost effectiveness of treatment modalities for hepatocellular carcinoma in SEER-Medicare.

Shaya FT, Breunig IM, Seal B, Mullins CD, Chirikov VV, Hanna N. Shaya FT, et al. Among authors: mullins cd. Pharmacoeconomics. 2014 Jan;32(1):63-74. doi: 10.1007/s40273-013-0109-7. Pharmacoeconomics. 2014. PMID: 24293197

10

Regression-Based Approaches to Patient-Centered Cost-Effectiveness Analysis.

Goto D, Shih YT, Lecomte P, Olson M, Udeze C, Park Y, Mullins CD. Goto D, et al. Among authors: mullins cd. Pharmacoeconomics. 2017 Jul;35(7):685-695. doi: 10.1007/s40273-017-0505-5. Pharmacoeconomics. 2017. PMID: 28378193

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

345 results

Search Page